Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)

27.24
Delayed Data
As of Sep 22
 +0.32 / +1.19%
Today’s Change
13.02
Today|||52-Week Range
37.75
+60.61%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Arcturus Therapeutics Holdings Inc have a median target of 51.00, with a high estimate of 140.00 and a low estimate of 18.00. The median estimate represents a +87.22% increase from the last price of 27.24.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Arcturus Therapeutics Holdings Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.40
Sales
$17.8M
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 29.20%
 
 
 
 
 
 
Growthannually -474.30%
 
 
 
 
 
 

Sales

Growthquarterly 69.51%
 
 
 
 
 
 
Growthannually -22.09%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.